| |
| |
|
| Insider
Information: |
Virani Shafique |
| Relationship: |
Chief Business Officer |
| City: |
Salt Lake City |
| State: |
UT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
136,748 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,279,961 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
136,748 |
|
|
| Total
Value |
$1,279,961 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Recursion Pharmaceuticals, Inc. |
RXRX |
Chief Business Officer |
2024-01-16 |
136,748 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RXRX |
Recursion Pharmaceuticals... |
Chief Corp. Dev. Officer |
• – – |
2021-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
18,000 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Corp. Dev. Officer |
• – – |
2022-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
42,943 |
106,370 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
117,090 |
192,840 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2022-08-16 |
4 |
AS |
$12.61 |
$378,444 |
D/D |
(30,000) |
98,773 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2022-09-15 |
4 |
AS |
$13.34 |
$133,635 |
D/D |
(10,000) |
93,773 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2022-10-14 |
4 |
AS |
$10.63 |
$109,180 |
D/D |
(10,000) |
88,773 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2022-11-15 |
4 |
AS |
$11.92 |
$123,123 |
D/D |
(10,000) |
83,160 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2022-12-15 |
4 |
AS |
$8.85 |
$88,525 |
D/D |
(10,000) |
78,160 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2023-01-17 |
4 |
AS |
$9.16 |
$91,561 |
D/D |
(10,000) |
73,160 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2023-02-15 |
4 |
AS |
$8.33 |
$62,358 |
D/D |
(7,486) |
189,846 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2023-02-16 |
4 |
AS |
$8.42 |
$14,887 |
D/D |
(1,768) |
187,332 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2023-06-01 |
4 |
AS |
$8.58 |
$214,500 |
D/D |
(25,000) |
161,819 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2023-06-02 |
4 |
AS |
$8.93 |
$159,534 |
D/D |
(17,865) |
143,954 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2023-07-17 |
4 |
AS |
$11.72 |
$351,600 |
D/D |
(30,000) |
143,954 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2023-07-18 |
4 |
AS |
$13.74 |
$412,200 |
D/D |
(30,000) |
143,954 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2023-07-25 |
4 |
AS |
$14.30 |
$286,000 |
D/D |
(20,000) |
143,954 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2023-07-26 |
4 |
AS |
$14.41 |
$288,200 |
D/D |
(20,000) |
143,954 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2023-08-15 |
4 |
AS |
$9.25 |
$166,500 |
D/D |
(18,000) |
140,351 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2023-09-15 |
4 |
AS |
$8.66 |
$155,880 |
D/D |
(18,000) |
140,351 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2023-10-16 |
4 |
AS |
$6.30 |
$113,400 |
D/D |
(18,000) |
140,351 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2023-11-15 |
4 |
AS |
$6.51 |
$117,180 |
D/D |
(18,000) |
140,351 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2023-12-15 |
4 |
AS |
$9.60 |
$172,800 |
D/D |
(18,000) |
136,748 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Business Officer |
• – – |
2024-01-16 |
4 |
AS |
$10.93 |
$196,740 |
D/D |
(18,000) |
136,748 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Corp. Dev. Officer |
• – – |
2021-04-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(18,000) |
0 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Corp. Dev. Officer |
• – – |
2022-02-04 |
4 |
D |
$11.40 |
$12,700 |
D/D |
(1,114) |
105,256 |
0 |
- |
|
52 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
